Specialized Center of Research Program (SCOR) supports interdisciplinary investigator teams pursuing integrated blood cancer research to move laboratory discoveries toward clinical use.
Academic Clinical Trials Program (ACT) supports academic investigators conducting blood cancer trials to test new treatments, expand existing therapy uses, and improve care for unmet medical needs.
Grant Applications - CLL Global Research Foundation supports researchers studying CLL immunity, disease progression, and new treatments to accelerate advances in clinical care and the control and cure of CLL.
LCFA/IASLC Translational Thoracic Oncology Research Grants support early-career investigators studying lung cancer to improve detection, diagnosis, treatment, and patient care through translational research.
Scholar in Clinical Research: Career Development Program (CDP) 2026–2027 supports clinical investigators’ salaries to advance patient-involved research on blood cancer prevention, diagnosis, or treatment.